Literature DB >> 28921279

Correlation between renal function and pharmacokinetic parameters of inorganic fluoride following sevoflurane anesthesia.

Tomoki Nishiyama1, Narushi Toda2.   

Abstract

We studied the correlation between renal function and pharmacokinetic parameters of inorganic fluoride following sevoflurane anesthesia. In 30 neurosurgical patients aged 40-70 years, anesthesia was induced with midazolam and sevoflurane and maintained with sevoflurane and nitrous oxide in oxygen. Serum and urine inorganic fluoride (F-) levels and β2-microglobulin (BMG), blood urea nitrogen (BUN), and serum creatinine (Cr) were measured during and after anesthesia. The decrease rate of serum F- level and the area under the curve (AUC) of serum F- were calculated. Correlations among sevoflurane dosage, duration of administration, peak serum F- level, AUC, the decrease rate of serum F- level, and the maximum values in BUN, Cr, and urine BMG during the study were investigated. Urine BMG increased significantly after surgery but returned to the preoperative level in a week. BUN, Cr, and serum BMG remained within normal ranges during the study. Sevoflurane dosage and duration of administration were significantly correlated with AUC and the maximum value of urine BMG, but not with the peak serum F- level or the decrease rate of serum F-. AUC was significantly correlated with the maximum value of urine BMG. In sevoflurane anesthesia, sevoflurane dosage, duration of administration, and AUC affected urine BMG level, but not peak serum F-.

Entities:  

Keywords:  Inorganic fluoride; Renal function; Sevoflurane; β2-Microglobulin

Year:  1995        PMID: 28921279     DOI: 10.1007/BF02479842

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  9 in total

1.  [Effects of enflurane, isoflurane, and sevoflurane on renal tubular functions].

Authors:  H Kumano; S Osaka; N Ishimura; M Nishiwada
Journal:  Masui       Date:  1992-11

2.  [Renal effects and metabolism of sevoflurane in Fisher 3444 rats: an in-vivo and in-vitro comparison with methoxyflurane].

Authors:  T L Cook; W J Beppu; B A Hitt; J C Kosek; R I Mazze
Journal:  Anesthesiology       Date:  1975-07       Impact factor: 7.892

Review 3.  Fate of fluorinated metabolites of inhalation anesthetics in man.

Authors:  D A Holaday; V Fiserova-Bergerova
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

4.  Methoxyflurane nephrotoxicity. A study of dose response in man.

Authors:  M J Cousins; R I Mazze
Journal:  JAMA       Date:  1973-09-24       Impact factor: 56.272

5.  Renal dysfunction associated with methoxyflurane anesthesia. A randomized, prospective clinical evaluation.

Authors:  R I Mazze; G L Shue; S H Jackson
Journal:  JAMA       Date:  1971-04-12       Impact factor: 56.272

6.  Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans.

Authors:  Y Kobayashi; R Ochiai; J Takeda; H Sekiguchi; K Fukushima
Journal:  Anesth Analg       Date:  1992-05       Impact factor: 5.108

7.  Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function.

Authors:  E J Frink; H Ghantous; T P Malan; S Morgan; J Fernando; A J Gandolfi; B R Brown
Journal:  Anesth Analg       Date:  1992-02       Impact factor: 5.108

8.  Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers.

Authors:  D A Holaday; F R Smith
Journal:  Anesthesiology       Date:  1981-02       Impact factor: 7.892

9.  Biotransformation of sevoflurane in dogs and rats.

Authors:  L Martis; S Lynch; M D Napoli; E F Woods
Journal:  Anesth Analg       Date:  1981-04       Impact factor: 5.108

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.